LymphoSign Journal publishes novel clinical, translational, or basic research articles aimed at clinicians and scientists in the fields of immunology, gastroenterology, neurology, dermatology, infectious diseases, rheumatology, and hematology. The focus is on defining the molecular basis and treatment of various immune disorders like innate or adaptive immunodeficiency, bone marrow failure, autoimmunity and auto inflammatory disorders and lymphoid malignancies. The Journal also publishes papers that can directly and immediately improve diagnosis and management of patients, including practice guidelines and algorithms.
Implementation of newborn screening for SCID (Severe Combined Immunodeficiency), a major accomplishment for Immunodeficiency Canada.
“This is a monumental triumph to children born with severe combined immunodeficiency (SCID) and their families. Newborn screening will detect this problem early before complications develop, and allow for prompt life-saving interventions such as bone marrow transplantation. Read More »